Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon Schrader

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Research Initiative, Treatment Action : RITA|February 7, 2006
Edward's lessonShannon Schrader
Clinical Cornerstone|May 3, 2006
Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive malesShannon Schrader, Anthony Mills, Mark Scheperle, et al.
AIDS Research and Therapy|September 19, 2008
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsulesShannon Schrader, Susan K Chuck, Laurie W Rahn, et al.
Adult Learning (Washington, D.C.)|August 25, 2025
Crisis, Confidence, and Conserving Resources: Examining How Adult Education Students Navigate Stressors and MarginalizationFrances J Griffith, Sydney C Simmons, Shannon Schrader, et al.
The New England Journal of Medicine|August 16, 2018
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1Brinda Emu, Jeffrey Fessel, Shannon Schrader, et al.
AIDS (London, England)|June 12, 2003
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trialDavid W Haas, Carlos Zala, Shannon Schrader, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIVKathleen Squires, Adriano Lazzarin, José M Gatell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2004
CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studiesRoberto C Arduino, Esteban C Nannini, Maria Rodriguez-Barradas, et al.
Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Research Initiative, Treatment Action : RITA|February 7, 2006
Edward's lessonShannon Schrader
Clinical Cornerstone|May 3, 2006
Improvement in sexual functioning and satisfaction in nonresponders to testosterone gel: clinical effectiveness in hypogonadal, HIV-positive malesShannon Schrader, Anthony Mills, Mark Scheperle, et al.
AIDS Research and Therapy|September 19, 2008
Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsulesShannon Schrader, Susan K Chuck, Laurie W Rahn, et al.
Adult Learning (Washington, D.C.)|August 25, 2025
Crisis, Confidence, and Conserving Resources: Examining How Adult Education Students Navigate Stressors and MarginalizationFrances J Griffith, Sydney C Simmons, Shannon Schrader, et al.
The New England Journal of Medicine|August 16, 2018
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1Brinda Emu, Jeffrey Fessel, Shannon Schrader, et al.
AIDS (London, England)|June 12, 2003
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trialDavid W Haas, Carlos Zala, Shannon Schrader, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2004
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIVKathleen Squires, Adriano Lazzarin, José M Gatell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2004
CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studiesRoberto C Arduino, Esteban C Nannini, Maria Rodriguez-Barradas, et al.
Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.
Pageof 1